We are live on ! Find out more
MA

Madrone Advisors Portfolio holdings

AUM $1.39B
1-Year Est. Return 10.34%
This Fund
S&P 500
This Quarter Est. Return
-17.91%
1 Year Est. Return
-10.34%
3 Year Est. Return
-10.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$570M
AUM Growth
-$160M
Cap. Flow
+$204K
Cap. Flow %
0.04%
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
1
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
PACB icon
Pacific Biosciences
PACB
+$11.7M
2
GRAL
GRAIL Inc
GRAL
+$216K

Top Sells

Rank Stock Value
1
VT icon
Vanguard Total World Stock ETF
VT
+$10.1M
2
HLTH
Cue Health Inc. Common Stock
HLTH
+$1.34M
3
ILMN icon
Illumina
ILMN
+$251K

Sector Composition

Rank Sector Weight
1 Technology 53.34%
2 Healthcare 7.13%
3 Financials 0.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STNE icon
1
StoneCo
STNE
$2.16B
$304M 53.35%
25,339,276
– –
VT icon
2
Vanguard Total World Stock ETF
VT
$81.1B
$223M 39.21%
1,982,655
-91,949
-4% -$10.1M
PACB icon
3
Pacific Biosciences
PACB
$420M
$32M 5.63%
23,391,915
+5,800,000
+33% +$11.7M
ILMN icon
4
Illumina
ILMN
$33.1B
$8.35M 1.47%
80,000
-2,240
-3% -$251K
OPRT icon
5
Oportun Financial
OPRT
$345M
$1.81M 0.32%
623,295
– –
GRAL
6
GRAIL Inc
GRAL
$3.55B
$205K 0.04%
+13,333
New +$216K
HLTH
7
DELISTED
Cue Health Inc. Common Stock
HLTH
– –
-7,078,566
Closed -$1.34M

Similar funds

PL
Parkwood LLC Cleveland, Ohio $1.4B AUM 33.21% 1-Year Est. Return
SRAIM
Scheer Rowlett & Associates Investment Management Toronto, Ontario, Canada $1.39B AUM 42.31% 1-Year Est. Return
TIA
Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return
1SP
140 Summer Partners New York $1.4B AUM 73.38% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.4B AUM 23.96% 1-Year Est. Return
SP
Steelhead Partners Seattle, Washington $1.4B AUM 0.34% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.39B AUM 53.78% 1-Year Est. Return

Madrone Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Madrone Advisors held 7 positions worth $570M, down 22% from $730M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Madrone Advisors's Q2 2024 filing shows 1 new, 1 increased, 2 reduced and 1 closed positions. Its largest new stake was GRAIL Inc: 13,333 shares worth $205K. The largest sale was Vanguard Total World Stock ETF, an estimated $10.1M.

By sector, the portfolio is most concentrated in Technology at 53% of assets, down from 58% a quarter earlier, followed by Healthcare and Financials.

  • Madrone Advisors's largest Q2 2024 buy was GRAIL Inc: 13,333 shares worth $205K.
  • Madrone Advisors added most to Pacific Biosciences in Q2 2024, an estimated $11.7M increase.
  • Madrone Advisors's biggest Q2 2024 reduction was Vanguard Total World Stock ETF, cutting an estimated $10.1M.
  • Madrone Advisors fully exited Cue Health Inc. Common Stock in Q2 2024, selling an estimated $1.34M.
  • Madrone Advisors's ten largest holdings make up 100% of its $570M portfolio in Q2 2024.
  • Madrone Advisors opened 1 new position and closed 1 in Q2 2024.
  • Madrone Advisors's portfolio value fell 22% quarter-over-quarter to $570M.

Based on Madrone Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.